Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Archives of General Psychiatry

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/archgenpsychiatry.2011.2333PMID 22393202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects

  2011cited by this paper
• Selective Serotonin Reuptake Inhibitors Affect Neurobehavioral Development in the Human Fetus

  2011cited by this paper
• Antidepressant use during pregnancy and childhood autism spectrum disorders.

  2011cited by this paper
• Infant brain development and vulnerability to later internalizing difficulties: the Generation R study.

  2010cited by this paper
• A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction.

  2010cited by this paper
• Prevalence, cumulative incidence, monotherapy and combination therapy, and treatment duration of frequently prescribed psychoactive medications in the Netherlands: retrospective database analysis for the years 2000 to 2005.

  2010cited by this paper
• New perspectives on the neurodevelopmental effects of SSRIs.

  2010cited by this paper
• On Categorizing Gestational, Birth, and Neonatal Complications Following Late Pregnancy Exposure to Antidepressants: The Prenatal Antidepressant Exposure Syndrome

  2010cited by this paper
• The Generation R Study: design and cohort update 2010

  2010cited by this paper
• Fetal Exposure to Antidepressants and Normal Milestone Development at 6 and 19 Months of Age

  2010cited by this paper
• Mother's educational level and fetal growth: the genesis of health inequalities.

  2010cited by this paper
• Agreement between Maternal Cannabis Use during Pregnancy according to Self-Report and Urinalysis in a Population-Based Cohort: The Generation R Study

  2010cited by this paper
• Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R Study

  2010cited by this paper
• Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn

  2009cited by this paper
• Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study.

  2009cited by this paper
• Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.

  2009cited by this paper
• Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.

  2009cited by this paper
• Neonatal Fluoxetine Exposure Affects the Neuronal Structure in the Somatosensory Cortex and Somatosensory-Related Behaviors in Adolescent Rats

  2009cited by this paper
• Early parental depression and child language development.

  2009cited by this paper
• The impact of maternal depression in pregnancy on early child development

  2008cited by this paper
• Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities

  2008cited by this paper
• Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

  2008cited by this paper
• New charts for ultrasound dating of pregnancy and assessment of fetal growth: longitudinal data from a population‐based cohort study

  2008cited by this paper
• Intra‐ and interobserver reproducibility study of early fetal growth parameters

  2008cited by this paper
• Antepartum and postpartum exposure to maternal depression: different effects on different adolescent outcomes.

  2008cited by this paper
• Use of antidepressant medications during pregnancy: a multisite study.

  2008cited by this paper
• Neonatal Outcomes After Prenatal Exposure to Selective Serotonin Reuptake Inhibitor Antidepressants and Maternal Depression Using Population-Based Linked Health Data

  2007cited by this paper
• Fact: antidepressants and anxiolytics are not safe during pregnancy.

  2007cited by this paper
• Effects of maternal smoking in pregnancy on prenatal brain development. The Generation R Study

  2007cited by this paper
• Trends in psychotropic medication use among U.S. adults

  2007cited by this paper
• To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects

  2006cited by this paper
• The Generation R Study: Design and cohort profile

  2006cited by this paper
• Applied multilevel analysis : a practical guide

  2006cited by this paper
• Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

  2006cited by this paper
• Neonatal Antidepressant Exposure has Lasting Effects on Behavior and Serotonin Circuitry

  2006cited by this paper
• Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders.

  2005cited by this paper
• Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development.

  2004cited by this paper
• Fetal responses to placental insufficiency: an update

  2004cited by this paper
• Perinatal Risks of Untreated Depression during Pregnancy

  2004cited by this paper
• Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy.

  2003cited by this paper
• Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants.

  2003cited by this paper
• The developmental role of serotonin: news from mouse molecular genetics

  2003cited by this paper
• Placental passage of antidepressant medications.

  2003cited by this paper
• Outcomes of prenatal antidepressant exposure.

  2002cited by this paper
• Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta

  2002cited by this paper
• Developmentally regulated serotonin 5‐HT2B receptors

  2001cited by this paper
• Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors

  2001cited by this paper
• Effect of antenatal exposure to paroxetine (paxil) on growth and physical maturation of mice offspring.

  2000cited by this paper
• Regional brain volume abnormalities and long-term cognitive outcome in preterm infants.

  2000cited by this paper
• Selective facilitation of the serotonin1B receptor causes disorganization of thalamic afferents and barrels in somatosensory cortex of rat

  2000cited by this paper
• The use of fractional polynomials to model continuous risk variables in epidemiology.

  1999cited by this paper
• Regulated release of serotonin from axonal growth cones isolated from the fetal rat brain.

  1998cited by this paper
• SSRI safety in overdose.

  1998cited by this paper
• Psychiatric outcomes in low-birth-weight children at age 6 years: relation to neonatal cranial ultrasound abnormalities.

  1997cited by this paper
• Interaction 3: How to examine heterogeneity.

  1996cited by this paper
• Statistics notes: Interaction 3: How to examine heterogeneity

  1996cited by this paper
• Birth outcomes in pregnant women taking fluoxetine.

  1996cited by this paper
• Statistics Notes: Interaction 2: compare effect sizes not P values

  1996cited by this paper
• The impact of confounder selection criteria on effect estimation.

  1989cited by this paper
• Sonographic estimation of fetal weight. The value of femur length in addition to head and abdomen measurements.

  1984influential reference
• The Brief Symptom Inventory: an introductory report

  1983cited by this paper
• Postnatal development of high affinity neuronal recognition sites for 3H-5-HT in rat brain.

  1982cited by this paper
• The relationship between brain weight and head circumference from birth to age 18 years.

  1978cited by this paper
• Head circumference as an index of brain weight in the fetus and newborn.

  1977cited by this paper

• The association between gestational selective serotonin reuptake inhibitor (SSRI) treatment and newborn thyroid screen: a large-scale cohort study

  2025cites this paper
• Early pregnancy depressive symptoms and severe maternal morbidity.

  2025cites this paper
• Depression and antidepressant use in pregnancy and adverse maternal and offspring outcomes: a systematic review and meta-analysis

  2025cites this paper
• From Prescription to Pollution: Assessing the Ecological Impact and Treatment Technologies for Antidepressant Contaminants

  2025cites this paper
• Fetal Head Growth and Head Circumference at Birth in Children of Women with Psychotic Disorders and Population-Based Controls.

  2025cites this paper
• Maternal SSRI Use During Pregnancy: Links Between Gut Microbiome, Offspring Behaviour, and Brain Transcriptomics.

  2025cites this paper
• Trajectories of Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Perinatal Outcomes: A Longitudinal Register Study

  2025cites this paper
• Gestational vortioxetine exposure impairs pregnancy outcomes and fetal brain development via modulation of BDNF/Bax-Bcl2/5-HT pathways in rats

  2025cites this paper
• Use of serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) during pregnancy: Effect on fetal growth and long-term reproductive outcomes.

  2025cites this paper
• Maternal and Neonatal Risks of Untreated Major Depressive Disorder in Pregnancy

  2025cites this paper
• The association between perinatal depressive symptoms and child neurodevelopment.

  2024cites this paper
• Vilazodone exposure during pregnancy: Effects on embryo-fetal development, pregnancy outcomes and fetal neurotoxicity by BDNF/Bax-Bcl2/5-HT mediated mechanisms.

  2024cites this paper
• Disparities in Utilization and Delivery Outcomes for Women with Perinatal Mood and Anxiety Disorders

  2024cites this paper
• Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.

  2023cites this paper
• Screening prenatal depression to assess childbirth and neonatal complications: a cohort study

  2023cites this paper
• Maternal serotonin: implications for the use of selective serotonin reuptake inhibitors during gestation

  2023cites this paper
• Perinatal Depression: A Guide to Detection and Management in Primary Care

  2023cites this paper
• Understanding Perinatal Depression Care Gaps by Examining Care Access and Barriers in Perinatal Individuals With and Without Psychiatric History

  2023cites this paper
• In utero Exposure to Selective Serotonin Re-uptake Inhibitor Affects Murine Mandibular Development.

  2022cites this paper
• A qualitative examination of the implementation of a perinatal collaborative care program

  2022cites this paper
• Treatment of mental disorders of generative cycle in women

  2022cites this paper
• Pharmacologic Treatment for Perinatal Mental Health Disorders

  2022cites this paper
• Selective Serotonin Reuptake Inhibitors (SSRIs) in Pregnancy: An Updated Review on Risks to Mother, Fetus, and Child

  2022cites this paper
• Leveraging Digital Technology in Conducting Longitudinal Research on Mental Health in Pregnancy: Longitudinal Panel Survey Study

  2021cites this paper
• Trajectories of antenatal depression and adverse pregnancy outcomes.

  2021cites this paper
• Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes

  2021cites this paper
• Antenatal Antidepressant Prescription Associated With Reduced Fetal Femur Length but Not Estimated Fetal Weight

  2021cites this paper
• Roles of the Serotoninergic System in Coping with Traumatic Stress

  2021cites this paper
• Association of Antidepressant Continuation in Pregnancy and Infant Birth Weight

  2021cites this paper
• Increased Depression Screening and Treatment Recommendations After Implementation of a Perinatal Collaborative Care Program.

  2021cites this paper
• Use of antidepressants during pregnancy and neonatal outcomes: An umbrella review of meta-analyses of observational studies.

  2020cites this paper
• Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment

  2020cites this paper
• The effects of maternal SSRI exposure on the serotonin system, prefrontal protein expression and behavioral development in male and female offspring rats.

  2020cites this paper
• A population-based study of concurrent prescriptions of opioid analgesic and selective serotonin reuptake inhibitor medications during pregnancy and risk for adverse birth outcomes.

  2020cites this paper
• The Association Between Prenatal Exposure to Antidepressants and Autism: Some Research and Public Health Aspects

  2020cites this paper
• Maternal use of antidepressants during pregnancy and risks for adverse perinatal outcomes: a meta-analysis.

  2020cites this paper
• Lithium exposure during pregnancy increases fetal growth

  2020cites this paper
• An analysis of online pregnancy message boards: Mother-to-mother advice on medication use.

  2020cites this paper
• Factors associated with re-initiation of antidepressant treatment following discontinuation during pregnancy: a register-based cohort study

  2020cites this paper
• Epidemiology of Child Psychopathology

  2020cites this paper
• Perinatal fluoxetine exposure disrupts the circadian response to a phase-shifting challenge in female rats

  2020cites this paper
• Antidepressant Use in Depressed Women During Pregnancy and the Risk of Preterm Birth: A Systematic Review and Meta-Analysis of 23 Cohort Studies

  2020cites this paper
• Perinatal fluoxetine treatment and dams' early life stress history alter affective behavior in rat offspring depending on serotonin transporter genotype and sex.

  2020cites this paper
• Medikamentöse Behandlung psychischer Störungen in Schwangerschaft und Stillzeit

  2019cites this paper
• SSRIs and SNRIs (SRI) in Pregnancy: Effects on the Course of Pregnancy and the Offspring: How Far Are We from Having All the Answers?

  2019cites this paper
• Influences of Maternal Vulnerability and Antidepressant Treatment during Pregnancy on the Developing Offspring

  2019cites this paper
• Prenatal maternal antidepressants, anxiety, and depression and offspring DNA methylation: epigenome-wide associations at birth and persistence into early childhood

  2019cites this paper
• The effect of antenatal depression and antidepressant treatment on placental tissue: a protein-validated gene expression study

  2019cites this paper
• Safe Expectations: Current State and Future Directions for Medication Safety in Pregnancy Research.

  2019cites this paper
• Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes

  2019cites this paper
• Transcranial Magnetic Stimulation for Major Depressive Disorder in Pregnancy: A Literature Review

  2019cites this paper
• Pharmacological exposures may precipitate craniosynostosis through targeted stem cell depletion

  2019cites this paper
• Leveraging Digital Technology in Conducting Longitudinal Research on Mental Health in Pregnancy: Longitudinal Panel Survey Study (Preprint)

  2019cites this paper
• The Impact of Trauma on the Fetus, the Infant, and the Child

  2019cites this paper
• Screening and Treatment After Implementation of a Universal Perinatal Depression Screening Program.

  2019cites this paper
• Antidepressant Medication Continuation During Pregnancy and Perinatal Outcomes, Including Gestational Weight Gain, Gestational Diabetes, and Birth Weight

  2018cites this paper
• Prenatal exposure to maternal and paternal depressive symptoms and white matter microstructure in children

  2018cites this paper
• Comparative effects of antidepressant medications and untreated major depression on pregnancy outcomes: a systematic review

  2018cites this paper
• ACEs and Pregnancy: Time to Support All Expectant Mothers

  2018cites this paper
• Perinatal anxiety: approach to diagnosis and management in the obstetric setting

  2018cites this paper
• Antidepressant use in pregnancy: are we closer to consensus?

  2018cites this paper
• A meta-analysis of selective serotonin reuptake inhibitors (SSRIs) use during prenatal depression and risk of low birth weight and small for gestational age.

  2018cites this paper
• Prenatal stress and child health outcomes 1 Title : Maternal psychological distress during pregnancy and childhood health outcomes : a narrative review Short title : Prenatal stress and child health outcomes Author list :

  2018cites this paper
• Maternal psychological distress during pregnancy and childhood health outcomes: a narrative review

  2018cites this paper
• Increased Risk for Mental Illness in Children in Foster Care

  2018cites this paper
• Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring

  2018cites this paper
• Discussing History of Mental Illness During Prenatal Genetic Counseling: Patient Interest and Comfort

  2018cites this paper
• Psychiatric disease

  2018cites this paper
• Public Health Perspectives on Depressive Disorders

  2017cites this paper
• Maternal depressive symptoms during pregnancy are associated with amygdala hyperresponsivity in children

  2017cites this paper
• Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta‐analysis of cohort studies

  2017cites this paper
• A systematic review of maternal antidepressant use in pregnancy and short- and long-term offspring’s outcomes

  2017cites this paper
• Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood

  2017cites this paper
• New Insights into How Serotonin Selective Reuptake Inhibitors Shape the Developing Brain

  2017cites this paper
• Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: A population-based cohort study.

  2017cites this paper
• Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring

  2017cites this paper
• Antidepressant therapy during pregnancy

  2017cites this paper
• Recent advances in understanding maternal perinatal mood disorders

  2017cites this paper
• Use of antidepressant medication in pregnancy and adverse neonatal outcomes: A population‐based investigation

  2017cites this paper
• Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes

  2017cites this paper
• Sculpting Cerebral Cortex with Serotonin in Rodent and Primate

  2017cites this paper
• Maternal General Health Status during Pregnancy and Adverse Birth Outcomes: Exposure Outcome in a Prospective Study

  2017cites this paper
• The Environmental Basis of Behavior

  2017cites this paper
• Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review

  2017cites this paper
• Impact Of Prenatal Exposure To Antidepressants On Adverse Birth Outcomes

  2017cites this paper
• Impact of antidepressant treatment during pregnancy on obstetric outcomes among women previously treated for depression: an observational cohort study

  2017cites this paper
• The concordance between self‐reported medication use and pharmacy records in pregnant women

  2017cites this paper
• Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women

  2017cites this paper
• Neonatal Outcomes in Women With Untreated Antenatal Depression Compared With Women Without Depression: A Systematic Review and Meta-analysis.

  2016cites this paper
• PRENATAL EXPOSURE TO MATERNAL AND PATERNAL DEPRESSIVE SYMPTOMS AND BRAIN MORPHOLOGY: A POPULATION‐BASED PROSPECTIVE NEUROIMAGING STUDY IN YOUNG CHILDREN

  2016cites this paper
• Effects of Fluoxetine on Human Embryo Development

  2016influential citation
• Is peripartum depression just another depression

  2016cites this paper
• Fluoxetine normalizes the effects of prenatal maternal stress on depression- and anxiety-like behaviors in mouse dams and male offspring.

  2016cites this paper
• The influence of n-3 fatty acids on maternal behavior and brain monoamines in the perinatal period.

  2016cites this paper
• Use of psychotropic drugs during pregnancy and breast‐feeding

  2016cites this paper
• Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research

  2016cites this paper
• Developmental fluoxetine and prenatal stress effects on serotonin, dopamine, and synaptophysin density in the PFC and hippocampus of offspring at weaning.

  2016cites this paper
• Exploring an Old Act for New Protections: How Title II of the ADA Protects Pregnant Women Undergoing Methadone Treatment from State Agency Child Removal

  2016cites this paper
• Evaluation of the Teratogenic Effects of the Antidepressant Drug Sertraline on Fetuses of Albino Rats

  2016cites this paper
• Making Sense Out of the Controversy: Use of SSRIs in Pregnancy

  2016cites this paper